Dr. Joseph Antin, MD

Claim this profile

Dana-Farber Cancer Institute (adult patients)

Studies Aplastic Anemia
Studies Dyskeratosis congenita
2 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.

Dana-Farber Cancer Institute (adult Patients)

Image of trial facility.

Dana-Farber Cancer Institute/Brigham And Women's Hospital

More about Joseph Antin, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Joseph Antin, MD has experience with

  • Alemtuzumab
  • Cyclosporins
  • Fludarabine
  • Mycophenolate Mofetil
  • Tacrolimus
  • Autologous CD34+ HSC Cells Transduced With The Lentiviral Vector Containing A ShRNA Targeting BCL11a

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Joseph Antin, MD specialize in?

Is Joseph Antin, MD currently recruiting for clinical trials?

Are there any treatments that Joseph Antin, MD has studied deeply?

What is the best way to schedule an appointment with Joseph Antin, MD?

What is the office address of Joseph Antin, MD?

Is there any support for travel costs?